SNU IBD Cohort Study : Searching for Characterization of High Risk Populations for Developing Inflammatory Bowel Disease
Observational · No treatment assigned · 1 site · Seoul National University Hospital
Official record & contacts on ClinicalTrials.gov ↗
In plain English
What this trial is testing
Condition(s) listed: Inflammatory Bowel Disease (IBD). This is an observational study: researchers collect information (for example questionnaires, samples, or scans) but the study does not assign a treatment.
Who can join
- Ages 10 and older
- Any sex
Some of the main requirements, copied from the record:
- first-degree relatives of Inflammatory Bowel Disease patients
- patients who are diagnosed with autoimmune diseases
- patients with functional gastrointestinal disorders who are ASCA-positive
There are also 2 reasons someone might not be able to join (exclusion criteria). Only the trial team can confirm whether you qualify.
What's involved
- About 500 participants are expected to take part.
- Start date: 2022-01-07.
- Main results expected around 2025-12-31 (estimate from the record).
- 1 study site listed (1 marked recruiting) in South Korea.
Main thing being measured
- Incidence of Inflammatory Bowel Disease (Up to 20 years from enrollment)
In the researchers’ words
The goal of this observational study is to investigate characteristics of individuals at high risk for developing Inflammatory Bowel Disease (IBD) in order to identify risk factors associated with its incidence. The main question it aims to answer is: What are the risk factors for developing Inflammatory Bowel Disease?
This is a short automatic summary built from the official record. A fuller plain-English card is coming; until then, please read the official record.
Questions to ask your doctor and the trial team
- Am I likely to qualify, given my health history?
- What would I have to do, and how often would I need to visit?
- Could I get a placebo? What happens to my current treatment?
- What are the possible risks and benefits?
- Are travel or other costs covered?
- What happens after the trial ends?
Official details
| Status | Recruiting |
|---|---|
| Phase | Observational |
| Study type | Observational |
| Conditions | Inflammatory Bowel Disease (IBD) |
| Lead sponsor | Seoul National University Hospital |
| Enrollment | 500 (estimated) |
| Start date | 2022-01-07 |
| Primary completion (est.) | 2025-12-31 |
| First posted | 2025-06-10 |
| Last updated | 2025-06-10 |
| Official title | SNU IBD Cohort Study : Searching for Characterization of High Risk Populations for Developing Inflammatory Bowel Disease (SNU PREVENT) |
| ClinicalTrials.gov ID | NCT07011979 |
Interventions
- None listed
Full eligibility criteria (from the record)
Inclusion Criteria: * first-degree relatives of Inflammatory Bowel Disease patients * patients who are diagnosed with autoimmune diseases * patients with functional gastrointestinal disorders who are ASCA-positive Exclusion Criteria: * Patients with symptoms such as a 10% weight loss within 3 months, abdominal pain, hematochezia, or diarrhea will undergo colonoscopy, and those diagnosed with Inflammatory Bowel Disease will be excluded. * Treatment history of Diabetes Mellitus, Irritable Bowel Syndrome, or colon cancer.
Locations (1)
| Site | City | Country | Site status |
|---|---|---|---|
| Seoul National University Hospital | Seoul | South Korea | Recruiting |
For contacts at each site, use the official record.
Information only, not medical advice. Talk to your doctor and the trial team before making any decision about a clinical trial.